Learn

Haematology Research Review Issue 136 with commentary by Professor Jeff Szer.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in Haematology. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

Details

In this issue we feature:

-  Fixed-duration acalabrutinib combinations in untreated CLL 
-  Sovleplenib for primary/secondary warm autoimmune haemolytic anaemia
-  Low-dose aspirin for post partum thromboprophylaxis
-  Treatment intensification according to residual disease in older patients with AML
-  Maintenance gilteritinib in FLT3-ITD AML
-  Long-term outcomes for add-on danicopan in PNH with extravascular haemolysis
-  Outpatient subcutaneous alemtuzumab for aplastic anaemia
-  Bendamustine-rituximab-bortezomib in relapsed/refractory Waldenström macroglobulinaemia
-  Long-term outcomes of methotrexate-cytarabine in Langerhans cell histiocytosis
-  Avatrombopag for ITP

To access this publication please click ‘Enrol Now’ and you’ll be directed to  the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.